What is Bed Bath & Beyond's operating income?

Bed Bath & Beyond's total operating income in 2025 was -$61.21 million, based on the following breakdown: Total Gross Profit: $257.52 million Total Operating Expenses: $318.74 million

Bed Bath & Beyond (BBBY) Financials

$5.80 -0.43 (-6.83%)

Closing price 07/2/2026 03:59 PM Eastern

Extended Trading

$5.86 +0.06 (+1.10%)

As of 07/2/2026 07:58 PM Eastern

Compare

Annual Income Statements for Bed Bath & Beyond

This table shows Bed Bath & Beyond's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	2.45	13	-110	-206	-122	56	389	-35	-308	-259	-85
Consolidated Net Income / (Loss)	1.22	11	-112	-218	-135	46	389	-35	-308	-259	-85
Net Income / (Loss) Continuing Operations	1.22	11	-112	-218	-63	95	172	-35	-308	-259	-85
Total Pre-Tax Income	3.12	21	-48	-220	-62	96	123	-34	-266	-258	-84
Total Operating Income	-0.53	6.92	-47	-217	-62	97	111	27	-144	-184	-61
Total Gross Profit	305	331	341	354	288	571	624	508	366	290	258
Total Revenue	1,658	1,800	1,745	1,822	1,435	2,494	2,756	1,929	1,561	1,395	1,045
Operating Revenue	1,658	1,800	1,745	1,822	1,435	2,494	2,756	1,929	1,561	1,395	1,045
Total Cost of Revenue	1,353	1,469	1,404	1,468	1,147	1,923	2,133	1,422	1,195	1,105	787
Operating Cost of Revenue	1,353	1,469	1,404	1,468	1,147	1,923	2,133	1,422	1,195	1,105	787
Total Operating Expenses	305	324	387	571	350	475	513	481	510	474	319
Selling, General & Admin Expense	82	89	91	164	97	98	87	80	90	74	54
Marketing Expense	124	148	181	274	141	261	302	215	225	239	143
Other Operating Expenses / (Income)	99	107	116	132	113	116	123	185	195	161	122
Total Other Income / (Expense), net	3.65	14	-1.10	-2.75	0.56	-0.23	12	-61	-122	-74	-23
Interest Expense	0.14	0.88	2.94	1.47	-1.20	0.84	0.56	-2.97	-12	-6.77	-5.05
Other Income / (Expense), net	3.63	14	1.18	-3.49	-0.64	0.61	13	-64	-134	-81	-28
Income Tax Expense	1.90	9.30	64	-2.38	1.06	1.36	-49	1.38	42	0.68	0.83
Basic Earnings per Share	$0.10	$0.49	($4.28)	($6.83)	($3.46)	$1.25	$8.18	($0.83)	($6.81)	($5.56)	($1.41)
Weighted Average Basic Shares Outstanding	24.61M	25.34M	25.04M	29.98M	34.87M	41.22M	42.98M	44.32M	45.21M	46.54M	60.13M
Diluted Earnings per Share	$0.10	$0.49	($4.28)	($6.83)	($3.46)	$1.24	$8.11	($0.83)	($6.81)	($5.56)	($1.41)
Weighted Average Diluted Shares Outstanding	24.70M	25.43M	25.04M	29.98M	34.87M	41.61M	43.33M	44.32M	45.21M	46.54M	60.13M
Weighted Average Basic & Diluted Shares Outstanding	24.50M	25.60M	25.70M	30.20M	40.33M	42.86M	43.12M	45.03M	45.57M	53.14M	69.01M

This table shows Bed Bath & Beyond's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Income / (Loss) Attributable to Common Shareholders	-63	-161	-74	-43	-61	-81	-40	-19	-4.52	-21	-16
Consolidated Net Income / (Loss)	-63	-161	-74	-43	-61	-81	-40	-19	-4.52	-21	-16
Net Income / (Loss) Continuing Operations	-63	-161	-74	-43	-61	-81	-40	-19	-4.52	-21	-16
Total Pre-Tax Income	-76	-95	-74	-42	-61	-81	-40	-19	-4.29	-21	-16
Total Operating Income	-41	-90	-58	-47	-45	-43	-23	-18	-12	-7.33	-18
Total Gross Profit	83	74	74	80	66	70	58	67	65	67	59
Total Revenue	373	384	382	398	311	303	232	282	257	273	248
Operating Revenue	373	384	382	398	311	303	232	282	257	273	248
Total Cost of Revenue	290	311	308	318	245	233	174	215	192	206	189
Operating Cost of Revenue	290	311	308	318	245	233	174	215	192	206	189
Total Operating Expenses	124	164	132	127	111	113	81	85	78	75	77
Selling, General & Admin Expense	24	24	20	19	18	18	14	14	12	13	15
Marketing Expense	58	71	68	66	52	53	31	38	36	38	32
Other Operating Expenses / (Income)	42	69	44	42	42	42	36	33	30	24	30
Total Other Income / (Expense), net	-36	-4.17	-16	4.54	-16	-38	-17	-1.15	8.16	-13	2.06
Interest Expense	-3.20	-3.19	-2.72	-2.31	-1.55	-0.19	-0.76	-0.89	-1.19	-2.22	-1.73
Other Income / (Expense), net	-39	-7.36	-19	2.23	-17	-39	-17	-2.04	6.98	-16	0.33
Income Tax Expense	-13	66	0.33	0.12	0.19	0.05	0.19	0.29	0.23	0.11	0.25
Basic Earnings per Share	($1.39)	($3.56)	($1.62)	($0.93)	($1.33)	($1.68)	($0.74)	($0.34)	($0.07)	($0.26)	($0.24)
Weighted Average Basic Shares Outstanding	45.23M	45.21M	45.59M	45.74M	45.77M	46.54M	53.66M	57.50M	60.33M	60.13M	69.05M
Diluted Earnings per Share	($1.39)	($3.56)	($1.62)	($0.93)	($1.33)	($1.68)	($0.74)	($0.34)	($0.07)	($0.26)	($0.24)
Weighted Average Diluted Shares Outstanding	45.23M	45.21M	45.59M	45.74M	45.77M	46.54M	53.66M	57.50M	60.33M	60.13M	69.05M
Weighted Average Basic & Diluted Shares Outstanding	45.30M	45.57M	45.74M	45.75M	45.82M	53.14M	57.68M	57.41M	68.85M	69.01M	73.94M

This table details how cash moves in and out of Bed Bath & Beyond's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	-11	13	20	-61	-28	404	-16	-132	-69	-117	16
Net Cash From Operating Activities	55	40	-35	-139	-82	196	81	-13	-19	-174	-57
Net Cash From Continuing Operating Activities	55	40	-35	-139	-35	227	98	-13	-19	-174	-57
Net Income / (Loss) Continuing Operations	1.22	11	-112	-218	-63	95	172	-35	-308	-259	-85
Consolidated Net Income / (Loss)	1.22	11	-112	-218	-135	46	389	-35	-308	-259	-85
Depreciation Expense	24	27	29	32	26	22	19	17	19	19	16
Non-Cash Adjustments To Reconcile Net Income	7.59	7.54	6.11	30	16	6.82	-1.69	82	188	96	33
Changes in Operating Assets and Liabilities, net	21	-10	38	17	-19	103	-91	-76	82	-31	-21
Net Cash From Investing Activities	-82	-79	-18	-111	-27	-24	-86	-33	-45	25	-49
Net Cash From Continuing Investing Activities	-82	-79	-18	-111	-13	-15	-56	-33	-45	25	-49
Purchase of Property, Plant & Equipment	-67	-72	-24	-29	-13	-15	-14	-15	-19	-14	-7.41
Acquisitions	-0.15	-4.75	-0.42	-9.60	-	0.00	0.00	-19	-26	-6.04	-23
Sale of Property, Plant & Equipment	-	-	-	-	-	-	-	0.00	0.00	51	0.00
Divestitures	-11	1.25	0.00	-13	-	-	-	0.00	0.00	10	6.25
Other Investing Activities, net	-0.17	0.03	0.07	-11	0.03	-0.40	-1.69	-0.44	0.37	-16	-25
Net Cash From Financing Activities	17	53	73	189	81	231	-11	-86	-5.49	33	122
Net Cash From Continuing Financing Activities	16	53	73	189	81	231	-13	-86	-5.49	33	122
Repayment of Debt	-1.84	-1.91	-62	-41	-0.21	-9.08	-4.40	-3.45	-1.69	-32	-8.46
Repurchase of Common Equity	-2.37	0.00	-10	-	-	0.00	0.00	-80	0.00	0.00	-6.22
Issuance of Debt	21	48	40	0.00	0.00	48	-	0.00	0.00	25	0.00
Issuance of Common Equity	0.00	0.00	106	145	83	196	0.00	0.92	0.00	43	137
Other Financing Activities, net	-0.10	-0.64	-1.20	84	-1.41	-2.59	-8.28	-3.70	-3.80	-3.33	-0.58

This table details how cash moves in and out of Bed Bath & Beyond's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Change in Cash & Equivalents	-18	-23	-46	-70	-45	45	-45	6.05	47	7.80	-40
Net Cash From Operating Activities	-9.64	-28	-35	-76	-42	-22	-51	16	-15	-6.49	-12
Net Cash From Continuing Operating Activities	-9.64	-28	-35	-76	-42	-22	-51	16	-15	-6.49	-12
Net Income / (Loss) Continuing Operations	-63	-161	-74	-43	-61	-81	-40	-19	-4.52	-21	-16
Consolidated Net Income / (Loss)	-63	-161	-74	-43	-61	-81	-40	-19	-4.52	-21	-16
Depreciation Expense	4.32	4.63	3.96	4.40	4.38	6.32	4.84	4.08	3.88	3.48	3.20
Non-Cash Adjustments To Reconcile Net Income	45	43	23	4.32	26	40	19	4.65	-3.25	13	3.94
Changes in Operating Assets and Liabilities, net	4.23	85	12	-42	-11	13	-35	26	-11	-2.52	-2.54
Net Cash From Investing Activities	-7.32	7.13	-9.13	5.82	-3.24	31	-13	-7.04	-10	-19	-27
Net Cash From Continuing Investing Activities	-7.32	7.13	-9.13	5.82	-3.24	31	-13	-7.04	-10	-19	-27
Purchase of Property, Plant & Equipment	-4.50	-2.64	-3.42	-4.53	-3.38	-2.99	-1.18	-1.81	-2.26	-2.16	-1.03
Acquisitions	-2.95	-0.03	-5.71	-0.45	0.13	-0.01	-13	-	-10	-0.19	-0.10
Divestitures	-	-	0.00	10	-	0.03	1.25	-	5.00	-	0.00
Other Investing Activities, net	0.12	9.80	0.01	0.54	0.01	-17	0.00	-5.23	-2.97	-16	-26
Net Cash From Financing Activities	-0.64	-2.14	-2.52	-0.08	0.52	35	19	-2.74	72	33	-0.63
Net Cash From Continuing Financing Activities	-0.64	-2.14	-2.52	-0.08	0.52	35	19	-2.74	72	33	-0.63
Repayment of Debt	-0.11	-0.92	0.65	-	0.54	-35	0.51	-6.16	-0.32	-2.48	0.35
Issuance of Common Equity	-	-	0.00	-	-	-	19	4.75	77	36	0.00
Other Financing Activities, net	-0.53	-1.22	-3.17	-0.08	-0.02	-0.06	-0.53	-0.01	-0.01	-0.04	-0.98

This table presents Bed Bath & Beyond's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	428	485	434	461	418	830	1,066	879	636	402	425
Total Current Assets	248	244	265	215	177	583	552	415	350	228	240
Cash & Equivalents	170	183	203	142	112	495	503	371	303	159	175
Restricted Cash	0.43	0.43	0.46	1.30	2.63	1.20	0.03	0.19	0.14	27	27
Accounts Receivable	16	28	30	36	25	23	21	18	19	16	21
Inventories, net	21	21	14	14	5.84	6.24	5.14	6.53	13	12	5.16
Prepaid Expenses	14	12	18	22	22	23	22	19	15	14	12
Plant, Property, & Equipment, net	94	135	129	135	130	114	109	27	28	24	14
Total Noncurrent Assets	86	106	39	111	110	134	405	437	258	151	172
Long-Term Investments	-	-	13	60	42	1.41	343	296	156	78	67
Noncurrent Note & Lease Receivables	-	-	-	0.00	25	17	13	7.46	3.47	6.86	5.16
Goodwill	15	15	15	23	27	6.16	6.16	6.16	6.16	6.16	6.16
Intangible Assets	15	11	7.34	13	12	-	-	0.01	25	30	45
Other Noncurrent Operating Assets	18	24	4.22	15	4.03	2.65	3.24	2.75	13	29	49
Total Liabilities & Shareholders' Equity	428	485	434	461	418	830	1,066	879	636	402	425
Total Liabilities	279	312	262	251	240	394	322	233	277	239	208
Total Current Liabilities	259	249	215	241	216	328	272	191	232	225	192
Short-Term Debt	1.06	3.26	-	-	-	-	-	-	-	-	16
Accounts Payable	123	106	85	103	75	110	102	75	106	82	90
Accrued Expenses	83	96	83	88	88	124	102	64	74	74	51
Current Deferred Revenue	51	42	46	51	42	72	59	44	50	43	34
Other Current Liabilities	0.58	1.63	0.18	0.48	11	8.09	8.75	4.41	2.81	26	0.93
Total Noncurrent Liabilities	20	63	47	9.03	24	66	49	42	44	14	15
Capital Lease Obligations	-	-	-	0.00	22	13	7.96	3.63	0.94	6.45	5.64
Other Noncurrent Operating Liabilities	6.97	6.89	7.12	5.96	2.32	4.08	3.30	3.48	9.11	7.91	9.75
Commitments & Contingencies	-	-	-	-	-	-	-	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	149	173	172	211	178	436	744	646	359	163	218
Total Preferred & Common Equity	150	175	176	132	115	374	744	646	359	163	218
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	150	175	176	132	115	374	744	646	359	163	218
Common Stock	370	383	495	658	765	971	961	983	1,008	1,073	1,239
Retained Earnings	-166	-154	-255	-459	-580	-525	-137	-174	-482	-740	-843
Treasury Stock	-52	-53	-64	-67	-69	-71	-79	-163	-166	-170	-176
Accumulated Other Comprehensive Income / (Loss)	-1.43	-1.54	-0.60	-0.58	-0.57	-0.55	-0.54	-0.52	-0.51	0.00	-2.57
Noncontrolling Interest	-1.09	-2.37	-3.51	79	63	63	0.00	-	-	0.00	0.36

This table presents Bed Bath & Beyond's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026
Total Assets	771	577	497	428	364	358	414	404
Total Current Assets	376	305	232	183	196	196	232	197
Cash & Equivalents	325	256	186	140	115	121	167	136
Restricted Cash	0.04	0.17	0.17	1.13	27	27	27	27
Accounts Receivable	20	23	19	15	18	23	17	24
Inventories, net	12	13	12	11	25	8.41	7.21	0.50
Prepaid Expenses	19	13	15	16	12	17	13	9.71
Plant, Property, & Equipment, net	110	27	28	27	19	16	15	13
Total Noncurrent Assets	285	244	237	218	148	146	168	195
Long-Term Investments	169	137	130	112	78	72	79	64
Noncurrent Note & Lease Receivables	4.35	2.76	2.95	1.96	6.13	5.76	5.40	4.94
Goodwill	6.16	6.16	6.16	6.16	6.16	6.16	6.16	6.16
Intangible Assets	26	31	31	31	33	33	45	45
Other Noncurrent Operating Assets	14	13	13	14	25	30	32	75
Total Liabilities & Shareholders' Equity	771	577	497	428	364	358	414	404
Total Liabilities	255	290	246	232	220	227	211	202
Total Current Liabilities	209	246	203	189	206	215	198	190
Short-Term Debt	-	-	-	-	25	18	18	16
Accounts Payable	85	116	91	88	78	111	94	92
Accrued Expenses	72	73	61	54	62	47	49	47
Current Deferred Revenue	47	55	48	45	41	38	36	35
Other Current Liabilities	4.19	2.41	2.72	1.81	0.84	0.81	0.91	0.95
Total Noncurrent Liabilities	45	44	43	43	14	11	14	12
Capital Lease Obligations	1.62	0.58	0.43	0.36	6.29	6.10	5.87	5.40
Other Noncurrent Operating Liabilities	9.36	8.85	8.74	8.52	7.92	5.33	7.77	6.50
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	516	288	250	196	143	131	203	202
Total Preferred & Common Equity	516	288	250	196	143	131	203	202
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	516	288	250	196	143	131	203	202
Common Stock	1,002	1,013	1,019	1,026	1,094	1,102	1,183	1,241
Retained Earnings	-321	-556	-598	-659	-780	-800	-804	-859
Treasury Stock	-165	-170	-170	-170	-170	-172	-176	-177
Accumulated Other Comprehensive Income / (Loss)	-0.51	-0.50	-0.50	-0.49	-	-	-	-2.57
Noncontrolling Interest	-	-	-	-	-	0.34	0.34	0.36

This table displays calculated financial ratios and metrics derived from Bed Bath & Beyond's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
DEI Shares Outstanding	25,234,316.00	25,383,283.00	25,023,328.00	32,146,065.00	35,249,070.00	42,765,117.00	43,014,524.00	45,739,758.00	45,304,946.00	-	68,845,575.00
DEI Adjusted Shares Outstanding	25,234,316.00	25,383,283.00	25,023,328.00	32,146,065.00	35,249,070.00	42,765,117.00	43,014,524.00	45,739,758.00	45,304,946.00	-	68,845,575.00
DEI Earnings Per Adjusted Shares Outstanding	0.10	0.49	-4.39	-6.41	-3.46	1.31	9.05	-0.77	-6.79	-	-1.23
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	10.74%	8.57%	-3.07%	4.40%	-21.22%	73.80%	10.53%	-30.01%	-19.08%	-10.64%	-25.12%
EBITDA Growth	-9.50%	85.65%	-124.09%	-1,398.91%	82.83%	467.05%	19.34%	-114.15%	-1,186.27%	4.97%	70.48%
EBIT Growth	-76.32%	580.52%	-315.47%	-385.51%	71.43%	254.37%	26.96%	-129.79%	-655.44%	4.77%	66.46%
NOPAT Growth	-102.63%	1,910.17%	-962.26%	-365.77%	71.27%	318.26%	62.68%	-87.81%	-633.10%	-61.69%	66.75%
Net Income Growth	-86.14%	821.97%	-1,095.04%	-94.39%	38.08%	134.27%	742.60%	-109.06%	-773.66%	15.93%	67.30%
EPS Growth	-72.22%	390.00%	-973.47%	-59.58%	49.34%	135.84%	554.03%	-110.23%	-720.48%	18.36%	74.64%
Operating Cash Flow Growth	-32.56%	-27.43%	-189.02%	-294.46%	41.26%	340.74%	-58.81%	-115.49%	-48.27%	-837.82%	67.47%
Free Cash Flow Firm Growth	-257.20%	-11.85%	139.99%	-907.29%	60.95%	487.92%	-66.46%	-68.93%	-272.18%	-474.30%	39.15%
Invested Capital Growth	86.99%	806.38%	-109.57%	325.95%	205.30%	-491.30%	55.72%	-13.47%	-87.49%	19.78%	52.39%
Revenue Q/Q Growth	0.60%	2.62%	-3.85%	-0.21%	-6.89%	14.89%	-2.03%	-9.72%	-1.29%	-5.51%	-2.77%
EBITDA Q/Q Growth	-7.36%	16.79%	-177.10%	-15.67%	73.21%	-12.47%	5.50%	-167.91%	-44.21%	6.86%	43.37%
EBIT Q/Q Growth	-57.71%	43.81%	-171.74%	-13.44%	59.69%	-17.02%	7.55%	-385.31%	-40.16%	5.83%	39.67%
NOPAT Q/Q Growth	-113.65%	59.35%	-92.22%	-13.44%	55.54%	-6.17%	-4.28%	-59.71%	-156.24%	10.19%	35.65%
Net Income Q/Q Growth	-54.17%	34.71%	-804.86%	18.34%	11.95%	623.46%	6.23%	-366.60%	-89.60%	23.55%	41.64%
EPS Q/Q Growth	-33.33%	32.43%	-895.35%	25.92%	15.61%	416.67%	4.92%	-515.00%	-89.17%	25.27%	50.18%
Operating Cash Flow Q/Q Growth	21.34%	-47.58%	-373.08%	-49.27%	24.31%	-4.76%	0.25%	-180.56%	11.50%	3.35%	21.13%
Free Cash Flow Firm Q/Q Growth	11.19%	-223.34%	138.35%	-436.72%	59.68%	-11.13%	-42.61%	268.18%	61.95%	-920.14%	4.02%
Invested Capital Q/Q Growth	-110.19%	-43.43%	-103.79%	-47.96%	-61.69%	-26.44%	34.88%	-175.62%	-307.09%	-24.78%	2.08%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	18.38%	18.41%	19.52%	19.43%	20.07%	22.91%	22.63%	26.31%	23.45%	20.80%	24.65%
EBITDA Margin	1.70%	2.91%	-0.72%	-10.38%	-2.26%	4.78%	5.16%	-1.04%	-16.57%	-17.62%	-6.95%
Operating Margin	-0.03%	0.38%	-2.67%	-11.92%	-4.35%	3.88%	4.03%	1.40%	-9.22%	-13.69%	-5.86%
EBIT Margin	0.19%	1.17%	-2.61%	-12.12%	-4.39%	3.90%	4.48%	-1.91%	-17.82%	-18.99%	-8.51%
Profit (Net Income) Margin	0.07%	0.62%	-6.41%	-11.94%	-9.39%	1.85%	14.11%	-1.83%	-19.72%	-18.55%	-8.10%
Tax Burden Percent	39.17%	54.75%	234.47%	98.92%	217.82%	47.85%	316.25%	104.09%	115.68%	100.27%	100.98%
Interest Burden Percent	100.48%	97.39%	105.01%	99.66%	98.10%	99.14%	99.55%	91.95%	95.68%	97.45%	94.31%
Effective Tax Rate	60.83%	45.25%	0.00%	0.00%	0.00%	1.41%	-39.65%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	18.11%	-148.26%	-5,178.62%	-204.64%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	12.79%	-95.59%	-5,143.85%	-152.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	0.00%	-11.13%	83.39%	5,064.95%	135.30%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (ROE)	0.88%	6.98%	-64.87%	-113.66%	-69.34%	15.04%	65.90%	-5.07%	-61.26%	-99.18%	-44.46%
Cash Return on Invested Capital (CROIC)	0.00%	-106.38%	0.00%	-1,587.62%	-305.95%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Return on Assets (OROA)	0.77%	4.62%	-9.89%	-49.32%	-14.35%	15.60%	13.03%	-3.79%	-36.73%	-51.05%	-21.48%
Return on Assets (ROA)	0.30%	2.46%	-24.36%	-48.62%	-30.65%	7.40%	41.03%	-3.62%	-40.66%	-49.88%	-20.45%
Return on Common Equity (ROCE)	0.88%	7.05%	-65.97%	-91.26%	-44.05%	11.97%	62.40%	-5.07%	-61.26%	-99.18%	-44.42%
Return on Equity Simple (ROE_SIMPLE)	0.81%	6.42%	-63.73%	-165.14%	-117.06%	12.36%	52.26%	-5.46%	0.00%	-159.03%	0.00%
Net Operating Profit after Tax (NOPAT)	-0.21	3.79	-33	-152	-44	95	155	19	-101	-134	-43
NOPAT Margin	-0.01%	0.21%	-1.87%	-8.35%	-3.04%	3.82%	5.63%	0.98%	-6.46%	-9.58%	-4.10%
Net Nonoperating Expense Percent (NNEP)	0.84%	5.32%	-52.67%	-34.77%	-52.64%	-13.89%	34.34%	-7.18%	-34.90%	-34.02%	-16.03%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	2.91%	-27.99%	-79.01%	-19.16%
Cost of Revenue to Revenue	81.62%	81.59%	80.48%	80.57%	79.93%	77.09%	77.37%	73.69%	76.55%	79.20%	75.35%
SG&A Expenses to Revenue	4.96%	4.96%	5.20%	9.03%	6.74%	3.92%	3.17%	4.13%	5.79%	5.33%	5.13%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	18.41%	18.02%	22.19%	31.35%	24.42%	19.03%	18.60%	24.91%	32.67%	34.49%	30.51%
Earnings before Interest and Taxes (EBIT)	3.10	21	-45	-221	-63	97	124	-37	-278	-265	-89
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	28	52	-13	-189	-32	119	142	-20	-259	-246	-73
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.06	2.53	9.10	3.31	2.16	5.49	3.41	1.37	3.49	1.39	1.73
Price to Tangible Book Value (P/TBV)	2.57	2.97	10.41	4.57	3.26	5.58	3.44	1.38	3.83	1.79	2.26
Price to Revenue (P/Rev)	0.19	0.25	0.92	0.24	0.17	0.82	0.92	0.46	0.80	0.16	0.36
Price to Earnings (P/E)	126.69	35.47	0.00	0.00	0.00	36.63	6.52	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.79%	2.82%	0.00%	0.00%	0.00%	2.73%	15.34%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	6.52	0.00	29.93	5.15	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	0.09	0.18	0.79	0.17	0.12	0.67	0.63	0.11	0.51	0.00	0.11
Enterprise Value to EBITDA (EV/EBITDA)	5.41	6.07	0.00	0.00	0.00	14.03	12.23	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	49.20	15.05	0.00	0.00	0.00	17.16	14.07	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	83.89	0.00	0.00	0.00	17.52	11.21	11.71	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	2.80	8.03	0.00	0.00	0.00	8.50	21.48	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	66.56	0.00	0.00	6.59	20.45	8.38	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.10	0.34	0.00	0.01	0.12	0.13	0.06	0.01	0.00	0.04	0.03
Long-Term Debt to Equity	0.09	0.32	0.00	0.01	0.12	0.13	0.06	0.01	0.00	0.04	0.03
Financial Leverage	-1.22	-0.87	-0.87	-0.98	-0.89	-1.15	-1.15	-1.09	-1.18	-1.41	-1.37
Leverage Ratio	2.89	2.83	2.66	2.34	2.26	2.03	1.61	1.40	1.51	1.99	2.17
Compound Leverage Factor	2.90	2.76	2.80	2.33	2.22	2.01	1.60	1.29	1.44	1.94	2.05
Debt to Total Capital	8.81%	25.52%	0.00%	1.44%	10.81%	11.11%	5.81%	0.56%	0.26%	3.81%	2.52%
Short-Term Debt to Total Capital	0.65%	1.40%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	8.17%	24.12%	0.00%	1.44%	10.81%	11.11%	5.81%	0.56%	0.26%	3.81%	2.52%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	-0.67%	-1.02%	-2.04%	36.94%	31.48%	12.76%	0.00%	0.00%	0.00%	0.00%	0.16%
Common Equity to Total Capital	91.85%	75.50%	102.04%	61.63%	57.71%	76.13%	94.19%	99.44%	99.74%	96.19%	97.31%
Debt to EBITDA	0.51	1.13	0.00	-0.02	-0.66	0.46	0.32	-0.18	0.00	-0.03	-0.08
Net Debt to EBITDA	-5.54	-2.37	0.00	1.06	4.49	-3.72	-5.63	33.02	1.77	1.05	3.63
Long-Term Debt to EBITDA	0.47	1.07	0.00	-0.02	-0.66	0.46	0.32	-0.18	0.00	-0.03	-0.08
Debt to NOPAT	-69.03	15.65	0.00	-0.02	-0.49	0.57	0.30	0.19	-0.01	-0.05	-0.13
Net Debt to NOPAT	747.12	-32.82	0.00	1.32	3.34	-4.65	-5.16	-35.13	4.54	1.93	6.14
Long-Term Debt to NOPAT	-63.97	14.79	0.00	-0.02	-0.49	0.57	0.30	0.19	-0.01	-0.05	-0.13
Altman Z-Score	3.99	4.25	6.66	1.95	1.50	6.00	7.84	4.37	2.89	-0.71	0.22
Noncontrolling Interest Sharing Ratio	-0.40%	-1.07%	-1.70%	19.71%	36.48%	20.42%	5.30%	0.00%	0.00%	0.00%	0.09%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.96	0.98	1.24	0.89	0.82	1.78	2.03	2.17	1.51	1.01	1.25
Quick Ratio	0.72	0.85	1.09	0.74	0.68	1.58	1.93	2.03	1.39	0.78	1.02
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-46	-52	21	-167	-65	253	85	26	-45	-157	-93
Operating Cash Flow to CapEx	81.96%	54.74%	-149.33%	-484.43%	-635.86%	1,320.92%	594.25%	-84.13%	-96.90%	0.00%	-765.51%
Free Cash Flow to Firm to Interest Expense	-330.83	-59.07	7.05	-113.92	0.00	302.33	152.85	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	389.40	45.11	-11.99	-94.64	0.00	234.46	145.54	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	-85.69	-37.31	-20.02	-114.18	0.00	216.71	121.05	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	4.12	3.94	3.80	4.07	3.27	4.00	2.91	1.98	2.06	2.69	2.53
Accounts Receivable Turnover	94.49	81.32	59.93	55.19	47.31	104.80	125.13	99.24	84.13	79.11	56.96
Inventory Turnover	53.30	69.27	80.81	105.55	115.00	318.23	374.79	243.80	122.16	89.87	94.22
Fixed Asset Turnover	22.75	15.77	13.22	13.80	10.84	20.46	24.69	28.27	57.18	54.58	56.08
Accounts Payable Turnover	11.49	12.82	14.65	15.62	12.89	20.76	20.11	16.03	13.19	11.75	9.16
Days Sales Outstanding (DSO)	3.86	4.49	6.09	6.61	7.71	3.48	2.92	3.68	4.34	4.61	6.41
Days Inventory Outstanding (DIO)	6.85	5.27	4.52	3.46	3.17	1.15	0.97	1.50	2.99	4.06	3.87
Days Payable Outstanding (DPO)	31.76	28.46	24.92	23.37	28.32	17.58	18.15	22.78	27.67	31.06	39.86
Cash Conversion Cycle (CCC)	-21.05	-18.70	-14.31	-13.30	-17.43	-12.95	-14.26	-17.60	-20.34	-22.38	-29.58
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	-6.89	49	-4.66	11	32	-126	-56	-63	-119	-95	-45
Invested Capital Turnover	-55.36	86.11	79.24	620.43	67.22	-53.24	-30.36	-32.44	-17.18	-13.06	-14.88
Increase / (Decrease) in Invested Capital	46	56	-53	15	22	-158	70	-7.50	-55	23	50
Enterprise Value (EV)	153	318	1,379	315	166	1,671	1,738	221	797	-32	113
Market Capitalization	310	444	1,599	437	249	2,051	2,538	886	1,254	226	376
Book Value per Share	$5.96	$6.91	$7.02	$4.10	$3.26	$8.74	$17.31	$14.12	$7.93	$3.50	$3.16
Tangible Book Value per Share	$4.77	$5.90	$6.14	$2.97	$2.16	$8.59	$17.16	$13.98	$7.23	$2.71	$2.42
Total Capital	164	232	172	214	199	491	790	649	360	169	224
Total Debt	14	59	0.00	3.07	22	55	46	3.63	0.94	6.45	5.64
Total Long-Term Debt	13	56	0.00	3.07	22	55	46	3.63	0.94	6.45	5.64
Net Debt	-156	-124	-217	-200	-146	-443	-800	-664	-458	-258	-263
Capital Expenditures (CapEx)	67	72	24	29	13	15	14	15	19	-37	7.41
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-180	-185	-153	-169	-164	-241	-224	-148	-185	-183	-154
Debt-free Net Working Capital (DFNWC)	-9.25	-1.59	51	-26	-39	255	279	223	118	2.65	48
Net Working Capital (NWC)	-10	-4.84	51	-26	-39	255	279	223	118	2.65	48
Net Nonoperating Expense (NNE)	-1.43	-7.46	79	66	91	49	-234	54	207	125	42
Net Nonoperating Obligations (NNO)	-156	-124	-177	-200	-146	-562	-800	-709	-478	-258	-263
Total Depreciation and Amortization (D&A)	25	31	33	32	31	22	19	17	19	19	16
Debt-free, Cash-free Net Working Capital to Revenue	-10.85%	-10.28%	-8.78%	-9.28%	-11.42%	-9.68%	-8.12%	-7.68%	-11.86%	-13.15%	-14.77%
Debt-free Net Working Capital to Revenue	-0.56%	-0.09%	2.90%	-1.44%	-2.69%	10.23%	10.14%	11.58%	7.54%	0.19%	4.59%
Net Working Capital to Revenue	-0.62%	-0.27%	2.90%	-1.44%	-2.69%	10.23%	10.14%	11.58%	7.54%	0.19%	4.59%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	($6.81)	($5.56)	($1.41)
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	45.21M	46.54M	60.13M
Adjusted Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	($6.81)	($5.56)	($1.41)
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	45.21M	46.54M	60.13M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	45.57M	53.14M	69.01M
Normalized Net Operating Profit after Tax (NOPAT)	-0.37	-6.90	-33	-152	-44	95	78	19	-101	-134	-43
Normalized NOPAT Margin	-0.02%	-0.38%	-1.87%	-8.35%	-3.04%	3.82%	2.82%	0.98%	-6.46%	-9.58%	-4.10%
Pre Tax Income Margin	0.19%	1.14%	-2.74%	-12.07%	-4.31%	3.87%	4.46%	-1.75%	-17.05%	-18.50%	-8.02%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	22.14	24.05	-15.48	-150.34	0.00	116.14	222.25	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	-1.49	4.32	-11.11	-103.57	0.00	113.78	278.98	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	-452.95	-58.36	-23.51	-169.87	0.00	98.39	197.76	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	-476.59	-78.10	-19.15	-123.11	0.00	96.03	254.49	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	-0.10%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	194.02%	0.00%	-9.03%	0.00%	0.00%	0.00%	0.00%	-227.37%	0.00%	0.00%	-7.35%

This table displays calculated financial ratios and metrics derived from Bed Bath & Beyond's official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
DEI Shares Outstanding	45,203,152.00	45,304,946.00	45,304,946.00	45,738,120.00	45,750,676.00	-	-	57,679,459.00	57,405,976.00	68,845,575.00	69,009,239.00
DEI Adjusted Shares Outstanding	45,203,152.00	45,304,946.00	45,304,946.00	45,738,120.00	45,750,676.00	-	-	57,679,459.00	57,405,976.00	68,845,575.00	69,009,239.00
DEI Earnings Per Adjusted Shares Outstanding	-1.39	-3.55	-1.63	-0.93	-1.33	-	-	-0.33	-0.08	-0.30	-0.24
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-18.89%	-5.05%	0.30%	-5.71%	-16.58%	-21.15%	-39.38%	-29.10%	-17.42%	-9.80%	6.91%
EBITDA Growth	-106.45%	-571.81%	-640.75%	49.79%	23.00%	19.42%	50.75%	60.78%	97.25%	74.02%	58.82%
EBIT Growth	-96.09%	-440.47%	-384.45%	47.28%	21.67%	16.77%	46.96%	55.52%	91.23%	71.77%	55.84%
NOPAT Growth	-823.27%	-3,316.58%	-587.77%	-1,006.17%	-10.43%	33.57%	59.07%	61.96%	72.45%	78.66%	21.56%
Net Income Growth	-70.43%	-937.93%	-617.26%	42.07%	3.20%	49.53%	46.01%	54.64%	92.59%	74.31%	58.91%
EPS Growth	-71.60%	-917.14%	-604.35%	42.94%	4.32%	52.81%	54.32%	63.44%	94.74%	84.52%	67.57%
Operating Cash Flow Growth	-128.14%	8.01%	-272.99%	-6,045.10%	-336.92%	21.78%	-47.13%	120.86%	64.11%	70.07%	76.83%
Free Cash Flow Firm Growth	-85.50%	-241.43%	210.83%	206.15%	193.55%	-628.22%	-198.43%	-131.25%	-138.00%	-15.71%	44.55%
Invested Capital Growth	349.54%	-87.49%	-1,022.48%	-246.99%	-233.14%	19.78%	64.51%	25.84%	39.33%	52.39%	92.43%
Revenue Q/Q Growth	-11.58%	2.99%	-0.57%	4.14%	-21.77%	-2.66%	-23.55%	21.79%	-8.88%	6.32%	-9.39%
EBITDA Q/Q Growth	6.30%	-23.66%	22.34%	44.20%	-43.68%	-29.41%	52.53%	55.56%	89.93%	-1,122.82%	24.76%
EBIT Q/Q Growth	6.20%	-22.76%	21.96%	41.34%	-39.37%	-30.45%	50.27%	50.80%	72.51%	-319.78%	22.20%
NOPAT Q/Q Growth	-863.29%	-120.96%	10.90%	18.29%	3.83%	1.52%	45.10%	24.07%	30.36%	41.10%	-148.25%
Net Income Q/Q Growth	14.21%	-155.35%	54.08%	42.41%	-43.34%	-33.15%	50.88%	51.61%	76.59%	-361.73%	21.45%
EPS Q/Q Growth	14.72%	-156.12%	54.49%	42.59%	-43.01%	-26.32%	55.95%	54.05%	79.41%	-271.43%	7.69%
Operating Cash Flow Q/Q Growth	-680.65%	-187.49%	-24.87%	-119.28%	44.50%	48.53%	-134.89%	131.09%	-195.52%	57.08%	-81.78%
Free Cash Flow Firm Q/Q Growth	-4.33%	92.66%	880.27%	11.60%	-8.06%	-151.93%	-82.67%	64.57%	-11.81%	-42.05%	1.69%
Invested Capital Q/Q Growth	-1.57%	-307.09%	-6.17%	32.08%	10.84%	-24.78%	53.03%	-41.93%	27.06%	2.08%	92.53%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	22.21%	19.21%	19.45%	20.14%	21.18%	22.98%	25.08%	23.73%	25.34%	24.60%	23.89%
EBITDA Margin	-20.18%	-24.23%	-18.93%	-10.14%	-18.63%	-24.76%	-15.38%	-5.61%	-0.62%	-7.13%	-5.92%
Operating Margin	-10.96%	-23.52%	-15.05%	-11.81%	-14.51%	-14.15%	-10.16%	-6.33%	-4.84%	-2.68%	-7.35%
EBIT Margin	-21.34%	-25.44%	-19.96%	-11.25%	-20.04%	-26.85%	-17.47%	-7.06%	-2.13%	-8.40%	-7.22%
Profit (Net Income) Margin	-16.89%	-41.88%	-19.34%	-10.70%	-19.60%	-26.80%	-17.22%	-6.84%	-1.76%	-7.63%	-6.62%
Tax Burden Percent	82.46%	170.17%	100.45%	100.28%	100.31%	100.06%	100.49%	101.51%	105.43%	100.53%	101.54%
Interest Burden Percent	95.98%	96.74%	96.44%	94.84%	97.51%	99.77%	98.12%	95.54%	78.33%	90.36%	90.33%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-707.74%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	-701.80%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	681.62%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (ROE)	-26.12%	-61.26%	-80.03%	-82.71%	-95.04%	-99.18%	-104.28%	-105.63%	-72.66%	-44.46%	-35.34%
Cash Return on Invested Capital (CROIC)	-208.79%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Return on Assets (OROA)	-39.17%	-52.44%	-42.59%	-26.46%	-49.33%	-72.18%	-46.20%	-18.63%	-5.43%	-21.22%	-19.93%
Return on Assets (ROA)	-31.00%	-86.34%	-41.26%	-25.17%	-48.25%	-72.06%	-45.55%	-18.07%	-4.48%	-19.28%	-18.28%
Return on Common Equity (ROCE)	-26.12%	-61.26%	-80.03%	-82.71%	-95.04%	-99.18%	-104.28%	-105.53%	-72.60%	-44.42%	-35.30%
Return on Equity Simple (ROE_SIMPLE)	-31.45%	0.00%	-129.09%	0.00%	0.00%	0.00%	-156.78%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	-29	-63	-40	-33	-32	-30	-16	-13	-8.72	-5.13	-13
NOPAT Margin	-7.67%	-16.47%	-10.53%	-8.26%	-10.16%	-9.90%	-7.11%	-4.43%	-3.39%	-1.88%	-5.14%
Net Nonoperating Expense Percent (NNEP)	-5.94%	-16.46%	-6.47%	-2.27%	-8.04%	-13.93%	-7.79%	-2.56%	1.61%	-6.04%	-1.86%
Return On Investment Capital (ROIC_SIMPLE)	-	-17.58%	-13.97%	-13.12%	-16.10%	-17.75%	-9.44%	-8.04%	-3.84%	-2.30%	-5.71%
Cost of Revenue to Revenue	77.79%	80.79%	80.55%	79.86%	78.82%	77.02%	74.92%	76.27%	74.66%	75.40%	76.11%
SG&A Expenses to Revenue	6.46%	6.28%	5.35%	4.65%	5.64%	5.89%	6.18%	4.99%	4.65%	4.83%	6.00%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	33.17%	42.74%	34.50%	31.94%	35.70%	37.13%	35.24%	30.06%	30.18%	27.28%	31.24%
Earnings before Interest and Taxes (EBIT)	-80	-98	-76	-45	-62	-81	-40	-20	-5.47	-23	-18
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-75	-93	-72	-40	-58	-75	-36	-16	-1.60	-20	-15
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.39	3.49	5.65	2.39	2.35	1.39	2.15	3.03	2.77	1.73	1.58
Price to Tangible Book Value (P/TBV)	1.48	3.83	6.49	2.81	2.89	1.79	2.95	4.31	3.72	2.26	2.12
Price to Revenue (P/Rev)	0.45	0.80	1.04	0.39	0.31	0.16	0.25	0.35	0.52	0.36	0.30
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	4.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	0.16	0.51	0.79	0.18	0.14	0.00	0.10	0.18	0.29	0.11	0.11
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	55.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.07	0.00	0.00	0.00	0.00	0.04	0.22	0.19	0.12	0.03	0.10
Long-Term Debt to Equity	0.07	0.00	0.00	0.00	0.00	0.04	0.04	0.05	0.03	0.03	0.03
Financial Leverage	-0.97	-1.18	-1.12	-1.03	-1.03	-1.41	-1.40	-1.39	-1.31	-1.37	-1.14
Leverage Ratio	1.44	1.51	1.58	1.59	1.68	1.99	2.18	2.24	2.11	2.17	2.22
Compound Leverage Factor	1.39	1.46	1.52	1.51	1.64	1.98	2.14	2.14	1.65	1.96	2.01
Debt to Total Capital	6.49%	0.26%	0.20%	0.17%	0.18%	3.81%	17.87%	15.77%	10.52%	2.52%	9.36%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	14.26%	11.85%	7.93%	0.00%	6.94%
Long-Term Debt to Total Capital	6.49%	0.26%	0.20%	0.17%	0.18%	3.81%	3.61%	3.91%	2.59%	2.52%	2.42%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.22%	0.15%	0.16%	0.16%
Common Equity to Total Capital	93.51%	99.74%	99.80%	99.83%	99.82%	96.19%	82.13%	84.02%	89.33%	97.31%	90.48%
Debt to EBITDA	-0.20	0.00	0.00	0.00	0.00	-0.03	-0.15	-0.13	-0.19	-0.08	-0.41
Net Debt to EBITDA	2.56	1.77	1.22	1.12	0.96	1.05	0.90	1.05	1.94	3.63	3.99
Long-Term Debt to EBITDA	-0.20	0.00	0.00	0.00	0.00	-0.03	-0.03	-0.03	-0.05	-0.08	-0.10
Debt to NOPAT	-0.91	-0.01	-0.01	0.00	0.00	-0.05	-0.28	-0.27	-0.36	-0.13	-0.53
Net Debt to NOPAT	11.67	4.54	3.36	2.15	1.69	1.93	1.71	2.17	3.74	6.14	5.23
Long-Term Debt to NOPAT	-0.91	-0.01	-0.01	0.00	0.00	-0.05	-0.06	-0.07	-0.09	-0.13	-0.14
Altman Z-Score	3.07	3.83	4.42	2.64	1.99	0.80	0.86	0.83	1.53	0.73	0.47
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.09%	0.09%	0.09%	0.10%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.79	1.51	1.24	1.14	0.97	1.01	0.95	0.91	1.17	1.25	1.03
Quick Ratio	1.65	1.39	1.14	1.01	0.82	0.78	0.64	0.67	0.93	1.02	0.84
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-109	-7.99	99	111	102	-53	-98	-35	-39	-55	-54
Operating Cash Flow to CapEx	-214.48%	-1,050.68%	-1,011.40%	-1,675.69%	-1,246.98%	-726.02%	-4,311.69%	873.08%	-670.51%	-300.70%	-1,148.59%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.84	2.06	2.13	2.35	2.46	2.69	2.65	2.64	2.55	2.53	2.76
Accounts Receivable Turnover	78.43	84.13	69.19	81.35	85.32	79.11	60.47	53.69	66.45	56.96	50.41
Inventory Turnover	136.43	122.16	127.85	133.27	104.70	89.87	51.77	84.63	89.15	94.22	63.95
Fixed Asset Turnover	14.59	57.18	23.25	22.32	21.57	54.58	53.14	50.92	51.15	56.08	66.12
Accounts Payable Turnover	14.12	13.19	12.24	13.85	13.65	11.75	9.99	8.57	8.94	9.16	9.46
Days Sales Outstanding (DSO)	4.65	4.34	5.28	4.49	4.28	4.61	6.04	6.80	5.49	6.41	7.24
Days Inventory Outstanding (DIO)	2.68	2.99	2.86	2.74	3.49	4.06	7.05	4.31	4.09	3.87	5.71
Days Payable Outstanding (DPO)	25.85	27.67	29.81	26.36	26.75	31.06	36.54	42.61	40.83	39.86	38.58
Cash Conversion Cycle (CCC)	-18.52	-20.34	-21.68	-19.14	-18.99	-22.38	-23.45	-31.50	-31.24	-29.58	-25.64
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	57	-119	-126	-85	-76	-95	-45	-63	-46	-45	-3.38
Invested Capital Turnover	92.22	-17.18	-27.85	-112.59	-155.65	-13.06	-14.60	-15.16	-17.55	-14.88	-44.15
Increase / (Decrease) in Invested Capital	80	-55	-139	-144	-133	23	81	22	30	50	41
Enterprise Value (EV)	256	797	1,234	283	208	-32	120	203	313	113	115
Market Capitalization	715	1,254	1,627	598	461	226	308	397	562	376	320
Book Value per Share	$11.42	$7.93	$6.31	$5.47	$4.29	$3.50	$2.70	$2.27	$3.53	$3.16	$2.93
Tangible Book Value per Share	$10.72	$7.23	$5.50	$4.66	$3.49	$2.71	$1.97	$1.60	$2.63	$2.42	$2.19
Total Capital	552	360	288	251	197	169	175	156	227	224	223
Total Debt	36	0.94	0.58	0.43	0.36	6.45	31	25	24	5.64	21
Total Long-Term Debt	36	0.94	0.58	0.43	0.36	6.45	6.29	6.10	5.87	5.64	5.40
Net Debt	-459	-458	-393	-316	-254	-258	-188	-195	-249	-263	-206
Capital Expenditures (CapEx)	4.50	2.64	3.42	4.53	3.38	2.99	1.18	1.81	2.26	2.16	1.03
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-159	-185	-197	-157	-147	-183	-126	-149	-142	-154	-140
Debt-free Net Working Capital (DFNWC)	166	118	60	29	-5.96	2.65	15	-1.12	52	48	22
Net Working Capital (NWC)	166	118	60	29	-5.96	2.65	-9.68	-20	34	48	6.62
Net Nonoperating Expense (NNE)	34	98	34	9.68	29	51	23	6.80	-4.20	16	3.65
Net Nonoperating Obligations (NNO)	-459	-478	-414	-336	-272	-258	-188	-195	-249	-263	-206
Total Depreciation and Amortization (D&A)	4.32	4.63	3.96	4.40	4.38	6.32	4.84	4.08	3.88	3.48	3.20
Debt-free, Cash-free Net Working Capital to Revenue	-10.06%	-11.86%	-12.61%	-10.22%	-9.99%	-13.15%	-10.15%	-13.17%	-13.26%	-14.77%	-13.24%
Debt-free Net Working Capital to Revenue	10.52%	7.54%	3.81%	1.90%	-0.40%	0.19%	1.22%	-0.10%	4.84%	4.59%	2.09%
Net Working Capital to Revenue	10.52%	7.54%	3.81%	1.90%	-0.40%	0.19%	-0.78%	-1.74%	3.17%	4.59%	0.62%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($1.39)	($3.56)	($1.62)	($0.93)	($1.33)	($1.68)	($0.74)	($0.34)	($0.07)	($0.26)	($0.24)
Adjusted Weighted Average Basic Shares Outstanding	45.23M	45.21M	45.59M	45.74M	45.77M	46.54M	53.66M	57.50M	60.33M	60.13M	69.05M
Adjusted Diluted Earnings per Share	($1.39)	($3.56)	($1.62)	($0.93)	($1.33)	($1.68)	($0.74)	($0.34)	($0.07)	($0.26)	($0.24)
Adjusted Weighted Average Diluted Shares Outstanding	45.23M	45.21M	45.59M	45.74M	45.77M	46.54M	53.66M	57.50M	60.33M	60.13M	69.05M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	45.30M	45.57M	45.74M	45.75M	45.82M	53.14M	57.68M	57.41M	68.85M	69.01M	73.94M
Normalized Net Operating Profit after Tax (NOPAT)	-29	-63	-40	-33	-32	-30	-16	-13	-8.72	-5.13	-13
Normalized NOPAT Margin	-7.67%	-16.47%	-10.53%	-8.26%	-10.16%	-9.90%	-7.11%	-4.43%	-3.39%	-1.88%	-5.14%
Pre Tax Income Margin	-20.48%	-24.61%	-19.25%	-10.67%	-19.54%	-26.79%	-17.14%	-6.74%	-1.67%	-7.59%	-6.52%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-0.65%	-4.29%	-7.35%	0.00%

Financials Breakdown Chart

Key Financial Trends

Beyond, Inc. (NYSE: BBBY) continues to show a company under significant financial strain, though there are a few signs of stabilization in the most recent quarter. Over the last four years, revenue has generally trended lower, losses have remained large, and cash generation has been inconsistent. The balance sheet still shows a meaningful cash position, but liquidity has tightened and working capital has become more pressured.

Cash remains substantial: As of Q1 2026, the company reported $135.8 million in cash and equivalents, plus $26.7 million in restricted cash.
Quarterly operating loss improved year over year: Operating loss narrowed to $18.2 million in Q1 2026 from $20.9 million in Q4 2025 and $23.2 million in Q1 2025.
Revenue held up sequentially: Q1 2026 revenue was $247.8 million, roughly in line with the prior quarter’s $273.4 million and above Q1 2025’s $231.7 million.
Gross profit margin remains around 24% to 25%: Gross profit was $59.2 million in Q1 2026, suggesting the company is still generating positive gross profit despite bottom-line losses.
Depreciation and other non-cash items continue to cushion reported losses: Q1 2026 net loss of $16.4 million was adjusted by $3.2 million of depreciation and other non-cash items in operating cash flow.
Share count has been elevated and volatile: Weighted average basic shares were 69.0 million in Q1 2026 versus 53.7 million in Q1 2025, which can pressure per-share results.
Balance sheet equity remains positive: Total equity was $202.5 million in Q1 2026, though this has been supported by a large common stock balance and has not translated into profitability.
Operating cash flow remains negative: Q1 2026 operating cash flow was a use of $11.8 million, after also being negative in Q4 2025 at $6.5 million.
Net losses have been persistent for years: The company posted losses in every quarter shown, including a $16.4 million loss in Q1 2026 and an $81.3 million loss in Q4 2024.
Liquidity is tightening: Cash and equivalents fell from $167.4 million in Q3 2025 to $135.8 million in Q1 2026, while total current liabilities were $190.1 million, leaving limited near-term flexibility.

Big picture: Beyond has made some progress on reducing quarterly losses compared with the more difficult periods in 2024, but the business is still not producing sustained profitability or positive operating cash flow. The company’s survival story appears to depend on maintaining cash, managing liabilities, and improving margins faster than revenue continues to erode.

For retail investors, this remains a high-risk turnaround situation rather than a fundamentally stable business.

07/03/26 06:37 AM ETAI Generated. May Contain Errors.

Bed Bath & Beyond Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Bed Bath & Beyond's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Bed Bath & Beyond's net income appears to be on an upward trend, with a most recent value of -$84.62 million in 2025, falling from $1.22 million in 2015. The previous period was -$258.80 million in 2024. Find out what analysts predict for Bed Bath & Beyond in the coming months.

Bed Bath & Beyond's total operating income in 2025 was -$61.21 million, based on the following breakdown:

Total Gross Profit: $257.52 million
Total Operating Expenses: $318.74 million

Over the last 10 years, Bed Bath & Beyond's total revenue changed from $1.66 billion in 2015 to $1.04 billion in 2025, a change of -37.0%.

Bed Bath & Beyond's total liabilities were at $207.53 million at the end of 2025, a 13.2% decrease from 2024, and a 25.6% decrease since 2015.

In the past 10 years, Bed Bath & Beyond's cash and equivalents has ranged from $112.27 million in 2019 to $503.34 million in 2021, and is currently $175.30 million as of their latest financial filing in 2025.

Over the last 10 years, Bed Bath & Beyond's book value per share changed from 5.96 in 2015 to 3.16 in 2025, a change of -47.0%.

Related Companies

Financial statements for NYSE:BBBY last updated on 7/2/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Bed Bath & Beyond (BBBY) Financials

Financials Breakdown Chart

Key Financial Trends

Bed Bath & Beyond Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Bed Bath & Beyond (BBBY) Financials

Annual Income Statements for Bed Bath & Beyond

Quarterly Income Statements for Bed Bath & Beyond

Annual Cash Flow Statements for Bed Bath & Beyond

Quarterly Cash Flow Statements for Bed Bath & Beyond

Annual Balance Sheets for Bed Bath & Beyond

Quarterly Balance Sheets for Bed Bath & Beyond

Annual Metrics And Ratios for Bed Bath & Beyond

Quarterly Metrics And Ratios for Bed Bath & Beyond

Financials Breakdown Chart

Key Financial Trends

Bed Bath & Beyond Financials - Frequently Asked Questions

When does Bed Bath & Beyond's fiscal year end?

How has Bed Bath & Beyond's net income changed over the last 10 years?

What is Bed Bath & Beyond's operating income?

How has Bed Bath & Beyond's revenue changed over the last 10 years?

How much debt does Bed Bath & Beyond have?

How much cash does Bed Bath & Beyond have?

How has Bed Bath & Beyond's book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools